During the Covid-19 crisis, the pharmaceutical sector took center stage, particularly with vaccine distribution. This urgent need led to hefty investments in cold chain logistics, ensuring that vaccines reached every corner of the globe safely—a trend that’s now benefiting the industry as a whole.
“Pharmaceuticals are crucial for our future,” shared Joel Wobma,pharma Director at Air France KLM Martinair Cargo. “With an aging population, we anticipate a surge in demand. The focus will shift towards more personalized and specialized healthcare solutions.” This perspective drives their ongoing investment in both pharmaceuticals and cold chain enhancements.
“The pandemic highlighted areas where we coudl improve,” Wobma noted. “We seized this opportunity to refine our processes, leading to better service quality and enhanced capabilities across the board. The heightened attention on pharma is definitely a silver lining for us.”
Advancements in Operations
A notable initiative by AFKLMP Cargo involves expanding its cool chain capacity at Paris Charles de Gaulle Airport to maintain temperatures between two and eight degrees Celsius. By bolstering resources and expertise—like CEIV and GDP certifications—they aim to elevate their service offerings.
“We’re revamping our entire network,” Wobma explained further. “One recent upgrade includes implementing thermal covers after noticing temperature fluctuations were compromising cargo quality.” This proactive approach aims to mitigate future issues effectively.
“We’re always assessing our operations for improvement opportunities,” he added, highlighting how these thermal covers exemplify their commitment to fulfilling customer expectations consistently.
Navigating External Challenges
the geopolitical landscape frequently enough gets overlooked when discussing pharmaceutical supply chains but can significantly impact operations. While predicting specific risks is tricky, it’s essential to consider how global politics might influence manufacturing locations or supply routes.
“Currently, I don’t foresee major threats specifically targeting our cool chain,” Wobma remarked. “However,external factors like tariff changes can still affect us despite being out of our control.”
“Staying adaptable is key; we must be ready to pivot based on market dynamics,” he continued. “My job involves keeping everyone informed internally while strategizing ways through these unpredictable challenges.”
A Glimpse Ahead: Lyon conference
Sponsoring the upcoming Logipharma conference gives AFKLMP an exciting platform not just for showcasing innovations but also for engaging with industry trends—complete with ice cream treats!
The team is gearing up with a fresh strategy focused on competitiveness while emphasizing strict temperature control standards and timely deliveries as top priorities moving forward.
“At this event, we’re bringing all of our expertise along with strong partnerships from within our network,” said Wobma enthusiastically about their participation.
“I’m particularly keen on exploring potential shifts within the industry that could reshape supply chains beyond traditional concerns like cost or efficiency.”
This curiosity extends into questions about technology’s role: “How will AI transform operations? What implications do emerging treatments like gene therapy have? will new packaging requirements necessitate adjustments?”
Taking Lessons from Peers
P
“Client demands evolve over time; thus it’s vital we stay ahead by anticipating what they’ll require down the line,” concluded Wobma thoughtfully.
Comments are closed, but trackbacks and pingbacks are open.